GAM Holding’s Bristol-Myers Squibb BMY Stock Holding History

GAM Holding’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-38,000	Closed	-$2.44M	–	352
2019 Q4	$2.44M	Sell	38,000 -2,000	-5%	-$115K	0.12%	213
2019 Q3	$2.03M	Buy	40,000 +35,000	+700%	+$1.64M	0.09%	245
2019 Q2	$227K	Sell	5,000 -32,000	-86%	-$1.49M	0.01%	826
2019 Q1	$1.76M	Buy	+37,000	New	+$1.84M	0.07%	278

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

GAM Holding's BMY Position: Q4 2025 in Review

GAM Holding reduced its Bristol-Myers Squibb (BMY) stake by 52% in Q4 2025, selling an estimated $4.61M and leaving 86,896 shares worth $4.69M. The position accounts for 0.3% of the portfolio, ranked #89.

GAM Holding first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $30.7M in Q4 2015. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

GAM Holding held 86,896 shares of Bristol-Myers Squibb worth $4.69M as of Q4 2025.
GAM Holding sold 95,873 Bristol-Myers Squibb shares in Q4 2025, an estimated $4.61M.
Bristol-Myers Squibb made up 0.3% of GAM Holding's portfolio in Q4 2025, its #89 holding.
GAM Holding first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
GAM Holding's Bristol-Myers Squibb position peaked at $30.7M in Q4 2015.
2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on GAM Holding's 13F filing for Q4 2025, filed 17 Feb 2026.